CCR5 deficiency decreases susceptibility to experimental cerebral malaria

Blood

Volumn 101, Issue 11, 2003, Pages 4253-4259

  Belnoue, Elodie ^b   Kayibanda, Michèle ^b   Deschemin, Jean Christophe ^b   Viguier, Mireille ^b   Mack, Matthias ^b   Kuziel, William A ^b   Rénia, Laurent ^a  

^a Hôpital Cochin ^*  (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; CHEMOKINE RECEPTOR CCR5; GAMMA INTERFERON; INTERLEUKIN 10; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; BRAIN MALARIA; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; DISEASE PREDISPOSITION; FEMALE; HELPER CELL; LEUKOCYTE; MALE; MYCOSIS; NEUROLOGIC DISEASE; NONHUMAN; PATHOGENESIS; PLASMODIUM BERGHEI; PRIORITY JOURNAL; PROTEIN FUNCTION; T LYMPHOCYTE; TH1 CELL; VIRUS INFECTION; WILD TYPE; ANIMAL; BIOSYNTHESIS; BONE MARROW TRANSPLANTATION; MALARIA; METABOLISM; MOUSE; MOUSE MUTANT; NEUTROPHIL CHEMOTAXIS; PHYSIOLOGY; SURVIVAL RATE; TISSUE DISTRIBUTION;

ANIMALS; BONE MARROW TRANSPLANTATION; CHEMOTAXIS, LEUKOCYTE; DISEASE SUSCEPTIBILITY; INTERFERON TYPE II; INTERLEUKIN-10; MALARIA, CEREBRAL; MICE; MICE, KNOCKOUT; PLASMODIUM BERGHEI; RECEPTORS, CCR5; SURVIVAL RATE; TISSUE DISTRIBUTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0038819121     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-05-1493     Document Type: Article

References (52)

1. Berendt AR, Turner GDH, Newbold CI. Cerebral malaria: the sequestration hypothesis. Parasitol Today. 1994;10:412-414.
2. Miller LH, Baruch DI, Marsh K, Doumbo OK. The pathogenic basis of malaria. Nature. 2002;415: 673-679.
3. Silamut K, Phu NH, Whitty C, et al. A quantitative analysis of the microvascular sequestration of malaria parasites in the human brain. Am J Pathol. 1999;155:395-410.
4. Patnaik JK, Das BS, Mishra SK, Mohanty S, Satpathy SK, Mohanty D. Vascular clogging, mononuclear cell margination, and enhanced vascular permeability in the pathogenesis of human cerebral malaria. Am J Trop Med Hyg. 1994;51:642-647.
5. Porta J, Carota A, Pizzolato GP, et al. Immunopathological changes in human cerebral malaria. Clin Neuropathol. 1993;12:142-146.
6. Brown HC, Chau TT, Mai NT, et al. Blood-brain barrier function in cerebral malaria and CNS infections in Vietnam. Neurology. 2000;55:104-111.
7. Brown H, Hien TT, Day N, et al. Evidence of blood-brain barrier dysfunction in human cerebral malaria. Neuropathol Appl Neurobiol. 1999;25: 331-340.
8. Hearn J, Rayment N, Landon DN, Katz DR, De Souza JB. Immunopathology of cerebral malaria: morphological evidence of parasite sequestration in murine brain microvasculature. Infect Immun. 2000;68:5364-5376.
9. Jennings VM, Lal AA, Hunter RL. Evidence for multiple pathologic and protective mechanisms of murine cerebral malaria. Infect Immun. 1998;66: 5972-5979.
10. Rest JR. Cerebral malaria in inbred mice, I: a new model and its pathology. Trans R Soc Trop Med Hyg. 1982;76:410-415.
11. Neill AL, Hunt NH. Pathology of fatal and resolving Plasmodium berghei cerebral malaria in mice. Parasitology. 1992;105:165-175.
12. Polder TW, Eling WMC, Curfs JHAJ, Jerusalem CR, Wijers-Rouw M. Ultrastructural changes in the blood-brain barrier of mice infected with Plasmodium berghei. Acta Leiden. 1992;60:31-46.
13. + T cells in experimental cerebral malaria. J Immunol. 2002;169:6369-6375.
14. Zlotnik A, Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity. 2000;12:121-127.
15. Mantovani A. The chemokine system: redundancy for robust outputs. Immunol Today. 1999; 20:254-257.
16. Bonecchi R, Bianchi G, Bordignon PP, et al. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med. 1998;187:129-134.
17. Edinger, A, Mankowski J, Doranz BJ, et al. CD4-independent, CCR5-dependent infection of brain capillary endothelial cells by a neurovirulent simian immunodeficiency virus strain. Proc Natl Acad Sci U S A. 1997;94:14742-14747.
18. Berger O, Gan X, Gujuluva C, Burns AR, et al. CXC and CC chemokine receptors on coronary and brain endothelia. Mol Med. 1999;5:795-805.
19. Shields PL, Morland CM, Salmon M, Qin S, Hubscher SG, Adams DH. Chemokine and chemokine receptor interactions provide a mechanism for selective T cell recruitment to specific liver compartments within hepatitis C-infected liver. J Immunol. 1999;163:6236-6243.
20. Mack M, Bruhl H, Gruber R, et al. Predominance of mononuclear cells expressing the chemokine receptor CCR5 in synovial effusions of patients with different forms of arthritis. Arthritis Rheum. 1999;42:981-988.
21. Segerer S, Mack M, Regele H, Kerjaschki D, Schlondorff D. Expression of the C-C chemokine receptor 5 in human kidney diseases. Kidney Int. 1999;56:52-64.
22. Trebst C, Sorensen TL, Kivisakk P, et al. CCR1+/CCR5+ mononuclear phagocytes accumulate in the central nervous system of patients with multiple sclerosis. Am J Pathol. 2001;159:1701-1710.
23. Huffnagle GB, McNeil LK, McDonald RA, et al. Role of C-C chemokine receptor 5 in organ-specific and innate immunity to Cryptococcus neoformans. J Immunol. 1999;163:4642-4646.
24. Glass WG, Liu MT, Kuziel WA, Lane TE. Reduced macrophage infiltration and demyelination in mice lacking the chemokine receptor CCR5 following infection with a neurotropic coronavirus. Virology. 2001;288:8-17.
25. Vigario AM, Belnoue E, Cumano A, et al. Inhibition of Plasmodium yoelii blood-stage malaria by interferon alpha through the inhibition of the production of its target cell, the reticulocyte. Blood. 2001;97:3966-3971.
26. Taverne J, Sheikh N, De Souza JB, Playfair JHL, Probert L, Kollias G. Anaemia and resistance to malaria in transgenic mice expressing human tumour necrosis factor. Immunology. 1994;82:397-403.
27. Mack M, Cihak J, Simonis C, et al. Expression and characterization of the chemokine receptors CCR2 and CCR5 in mice. J Immunol. 2000;166: 4697-4704.
28. Lopez AF, Strath M, Sanderson CJ. Differentiation antigens on mouse eosinophils and neutrophils identified by monoclonal antibodies. Br J Haematol. 1984;57:489-494.
29. Van Rooijen N, Sanders A, van den Berg TK. Apoptosis of macrophages induced by liposome-mediated intracellular delivery of clodronate and propamidine. J Immunol Methods. 1996;193:93-99.
30. Espevik T, Nissen-Meyer J. A highly sensitive cell line, WEHI clone 13, for measuring cytotoxic factor/tumor factor from human monocytes. J Immunol. 1986;95:99-107.
31. Mosmann TR. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65:55-63.
32. Yanez DM, Manning DD, Cooley AJ, Weidanz WP, van der Heyde HC. Participation of lymphocyte subpopulations in the pathogenesis of experimental murine cerebral malaria. J Immunol. 1996;157:1620-1624.
33. Boubou MI, Collette A, Voegtle D, Mazier D, Cazenave PA, Pied S. T cell response in malaria pathogenesis: selective increase in T cells carrying the TCR V(beta)8 during experimental cerebral malaria. Int Immunol. 1999;11:1553-1562.
34. Lou J, Lucas R, Grau GE. Pathogenesis of cerebral malaria: recent experimental data and possible applications for humans. Clin Microbiol Rev. 2001;14:810-820.
35. Amani V, Vigario AM, Belnoue E, et al. Involvement of IFN-γ receptor-mediated signaling in pathology and anti-malarial immunity induced by Plasmodium berphei infection. Eur J Immunol. 2000;30:1646-1655.
36. Chang WL, Jones SP, Lefer DJ, et al. CD8(+)-T-cell depletion ameliorates circulatory shock in Plasmodium berghei-infected mice. Infect Immun. 2001;69:7341-7348.
37. Robert C, Peyrol S, Pouvelle B, Gay-Andrieu F, Gysin J. Ultrastructural aspects of Plasmodium falciparum-infected erythrocyte adherence to endothelial cells of Saimiri brain microvasculature. Am J Trop Med Hyg. 1996;54:169-177.
38. Cinamon G, Giabovsky V, Winter E, et al. Novel chemokine functions in lymphocyte migration through vascular endothelium under shear flow. J Leukoc Biol. 2001;69:860-866.
39. Colotta F, Sciacca FL, Sironi M, Luini W, Rabiet MJ, Mantovani A. Expression of monocyte chemotactic protein-1 by monocytes and endothelial cells exposed to thrombin. Am J Pathol. 1994; 144:975-985.
40. Devergne O, Marfaing-Koka A, Schall TJ, et al. Production of the RANTES chemokine in delayed-type hypersensitivity reactions: involvement of macrophages and endothelial cells. J Exp Med. 1994;179:1689-1694.
41. Pober JS, Corran RS. Immunologic interactions of T lymphocytes with vascular endothelium. Adv Immunol. 1991;50:261-302.
42. Luo Y, Berman MA, Zhai Q, et al. RANTES stimulates inflammatory cascades and receptor modulation in murine astrocytes. Glia. 2002;39:19-30.
43. Hesselgesser J, Horuk R. Chemokine and chemokine receptor expression in the central nervous system. J Neurovirol. 1999;5:13-26.
44. Grau GE, Pointaire P, Piguet PF, et al. Late administration of monoclonal antibody to leukocyte function-antigen 1 abrogates incipient murine cerebral malaria. Eur J Immunol. 1991;21:2265-2267.
45. Eckwalanga M, Marussig M, Tavares MD, et al. Murine AIDS protects mice against experimental cerebral malaria: down-regulation by interleukin 10 of a T-helper type 1 CD4+ cell-mediated pathology. Proc Natl Acad Sci U S A. 1994;91:8097-8101.
46. Engwerda CR, Mynott TL, Sawhney S, De Souza JB, Bickle QD, Kaye PM. Locally up-regulated lymphotoxin alpha, not systemic tumor necrosis factor alpha, is the principle mediator of murine cerebral malaria. J Exp Med. 2002;195:1371-1377.
47. Sato N, Kuziel WA, Melby PC, et al. Defects in the generation of IFN-gamma are overcome to control infection with Leishmania donovani in CC chemokine receptor (CCR) 5-, macrophage inflammatory protein-1 alpha-, or CCR2-deficient mice. J Immunol. 1999;163:5519-5525.
48. Baggiolini M. Ckemokines and leukocyte traffic. Nature. 1998;392:565-568.
49. Dzenko KA, Andjelkovic AV, Kuziel WA, Packter JS. The chemokine receptor CCR2 mediates binding and internalization of monocyte chemoattractant protein 1 along brain microvessels. J Neurosci. 2001;21:9214-9223.
50. Andjelkovic AV, Pachter JS. Characterization of binding sites for chemokines MCP-1 and MIP-1alpha on human brain microvessels. J Neurechem. 2000;75:1898-1906.
51. Blanpain C, Lee B, Tuckoen M, et al. Multiple nonfunctional alleles of CCR5 are frequent in various human populations. Blood. 2000;96: 1638-1645.
52. Mummidi S, Bamshad M, Ahuja SS, et al. Evolution of human and non-human primate CC chemokine receptor 5 gene and mRNA. J Biol Chem. 2000;275:18946-18961.